Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
22h
Fin vs Fin on MSNZealthy vs Ro: Which Weight Loss Plan Works Best?Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...
Vitalik Buterin praises Railgun for blocking stolen zkLend funds, highlighting how compliant onchain privacy can prevent ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really does help curb drinking ...
2d
Daily Express US on MSNOzempic and Zepbound linked to rare eye conditions that could cause blindnessA new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why
There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...
A U.S. judge ordered federal agencies to restore access to health-related webpages and datasets removed by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results